S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
The single greatest medical breakthrough of all time? (Ad)
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
"The Bull Market Is Officially OVER"  (Ad)pixel
Microsoft strikes 10-year deal with Nintendo on Call of Duty
Could trawler cams help save world's dwindling fish stocks?
"The Bull Market Is Officially OVER"  (Ad)pixel
Southwest Airlines brings back dividend as travel rebounds
Closing prices for crude oil, gold and other commodities
S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
The single greatest medical breakthrough of all time? (Ad)
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
"The Bull Market Is Officially OVER"  (Ad)pixel
Microsoft strikes 10-year deal with Nintendo on Call of Duty
Could trawler cams help save world's dwindling fish stocks?
"The Bull Market Is Officially OVER"  (Ad)pixel
Southwest Airlines brings back dividend as travel rebounds
Closing prices for crude oil, gold and other commodities
S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
The single greatest medical breakthrough of all time? (Ad)
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
"The Bull Market Is Officially OVER"  (Ad)pixel
Microsoft strikes 10-year deal with Nintendo on Call of Duty
Could trawler cams help save world's dwindling fish stocks?
"The Bull Market Is Officially OVER"  (Ad)pixel
Southwest Airlines brings back dividend as travel rebounds
Closing prices for crude oil, gold and other commodities
S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
The single greatest medical breakthrough of all time? (Ad)
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
"The Bull Market Is Officially OVER"  (Ad)pixel
Microsoft strikes 10-year deal with Nintendo on Call of Duty
Could trawler cams help save world's dwindling fish stocks?
"The Bull Market Is Officially OVER"  (Ad)pixel
Southwest Airlines brings back dividend as travel rebounds
Closing prices for crude oil, gold and other commodities
NASDAQ:ELGX

Endologix - ELGX Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range
N/A
50-Day Range
$0.02
$0.22
52-Week Range
N/A
Volume
N/A
Average Volume
1.28 million shs
Market Capitalization
$382,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ELGX stock logo

About Endologix (NASDAQ:ELGX) Stock

Endologix, Inc. develops, manufactures, markets, and sells medical devices for the treatment of abdominal aortic aneurysms in the United States and internationally. The company offers minimally-invasive endovascular aneurysm repair (EVAR), including AFX (Anatomical Fixation) endovascular AAA system, which is a minimally invasive delivery system; VELA Proximal Endograft, which is designed for the treatment of proximal aortic neck anatomies with AFX; and the Ovation abdominal stent graft system. It also provides endovascular aneurysm sealing system (EVAS) product that is based on the Nellix EVAS system to seal the aneurysm, and provides blood flow to the legs through two blood lumens. In addition, the company offers proximal aortic extensions and limb extensions, which allow physicians to customize the implant to fit the patient's anatomy; and accessories to facilitate the delivery of its EVAR and EVAS products, including compatible guidewires, inflation devices, and snares. It sells its products through direct sales force, and a network of third party distributors and agents. The company was formerly known as Radiance Medical Systems, Inc. and changed its name to Endologix, Inc. in May 2002. Endologix, Inc. was founded in 1992 and is headquartered in Irvine, California.

Receive ELGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Endologix and its competitors with MarketBeat's FREE daily newsletter.

ELGX Stock News Headlines

See More Headlines

Receive ELGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Endologix and its competitors with MarketBeat's FREE daily newsletter.

ELGX Company Calendar

Last Earnings
5/11/2020
Today
12/08/2022

Industry, Sector and Symbol

Industry
Surgical & Medical Instruments
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:ELGX
CUSIP
29266S10
Fax
N/A
Employees
528
Year Founded
N/A

Profitability

Net Income
$-64,760,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$143.37 million
Book Value
$3.56 per share

Miscellaneous

Free Float
N/A
Market Cap
$382,000.00
Optionable
Optionable
Beta
0.73

Key Executives

  • Mr. John Onopchenko (Age 60)
    CEO & Director
  • Mr. Vaseem Mahboob (Age 50)
    Chief Financial Officer
  • Dr. Michael V. Chobotov (Age 58)
    Chief Technology Officer
  • Mr. Jeffrey S. Brown
    Chief Operations Officer
  • Mr. Jeremy B. Hayden (Age 49)
    Gen. Counsel













ELGX Stock - Frequently Asked Questions

How were Endologix's earnings last quarter?

Endologix, Inc. (NASDAQ:ELGX) issued its quarterly earnings data on Monday, May, 11th. The medical instruments supplier reported ($0.80) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.67) by $0.13. The medical instruments supplier earned $28.51 million during the quarter, compared to the consensus estimate of $28.50 million. Endologix had a negative trailing twelve-month return on equity of 63.96% and a negative net margin of 44.65%.

When did Endologix's stock split?

Shares of Endologix reverse split on the morning of Wednesday, March 6th 2019. The 1-10 reverse split was announced on Tuesday, March 5th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, March 5th 2019. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What other stocks do shareholders of Endologix own?
What is Endologix's stock symbol?

Endologix trades on the NASDAQ under the ticker symbol "ELGX."

How much money does Endologix make?

Endologix (NASDAQ:ELGX) has a market capitalization of $0.00 and generates $143.37 million in revenue each year. The medical instruments supplier earns $-64,760,000.00 in net income (profit) each year or ($2.19) on an earnings per share basis.

How many employees does Endologix have?

The company employs 528 workers across the globe.

How can I contact Endologix?

Endologix's mailing address is 2 MUSICK, IRVINE CA, 92618. The official website for the company is www.endologix.com. The medical instruments supplier can be reached via phone at 949-595-7200 or via email at investorrelations@endologix.com.

This page (NASDAQ:ELGX) was last updated on 12/8/2022 by MarketBeat.com Staff